Starling Oncology, Inc. (STLN): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$900.0K
As of 2020-12-31
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2020-12-31 | $900.0K | n/a | 2021-05-24, Balance as of period end |